Site icon pharmaceutical daily

Saudi Arabia Eye Drops Market Report to 2027 – Featuring Riyadh Pharma, Orchidia Pharmaceutical Industries and Pfizer Saudi Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Eye Drops Market, By Type (Prescription v/s Over-The-Counter), By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others), By Disease Indication, By Distribution Channel, By End User, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering.

Saudi Arabia eye drops market is projected to grow at a formidable rate during the forecast period. The growth can be attributed to the increasing incidences of eye infections and rising awareness among population regarding eye care to maintain good eye health.

Industrialization and urbanization activities release harmful elements in the environment that impact the air quality. Prolonged exposure of eyes to these irritants can cause severe damage to the eyes and result in eye allergies, redness, dry eyes, allergies, etc., which is contributing towards the rising adoption of eye drops in Saudi Arabia. Several pharmaceutical companies and research institutes are working towards the drug discovery and developments in the eye care segment, which is projected to boost the Saudi Arabia eye drops market growth in the coming years.

Rapidly expanding geriatric population and rising incidences of diabetes have led to an increased adoption of eye drops, which is adding to the significant growth of eye drops market. Moreover, the surging demands from the healthcare industry and advances in technology have resulted into better eye drops that are mild on eyes and do not cause discomfort, which is contributing to the demand for eye drops in Saudi Arabia. As the world is being largely driven by digitization, people are spending more time on their smartphones, laptops, and other electronic screen gadgets, which is negatively impacting their eye health, leading to an enhanced demand for eye drops, significantly accelerating the Saudi Arabia eye drops market growth.

The Saudi Arabia eye drops market is segmented by type, drug class, disease indication, distribution channel, end user, competitional landscape, and regional distribution. Based on drug class, the market is further sub-segmented into antiallergy, anti-inflammatory, antiglaucoma, anti-VEGF, and others. Antiallergy drugs are expected to dominate the Saudi Arabia eye drops market due to rising incidences of eye allergies and infections from pollution, prolonged exposure to UV-A light emitted from electronic screens, and improper eye care. Besides, easier accessibility to antiallergy drugs on online platforms have contributed to their dominance. Antiglaucoma is expected to experience significant growth in Saudi Arabia eye drops market in the coming years due to rising incidences of diabetes and glucose-related disorders.

Objective of the Study:

Report Scope:

In this report, Saudi Arabia eye drops market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Saudi Arabia Eye Drops Market, By Type:

Saudi Arabia Eye Drops Market, By Drug Class:

Saudi Arabia Eye Drops Market, By Disease Indication:

Saudi Arabia Eye Drops Market, By Distribution Channel:

Saudi Arabia Eye Drops Market, By End User:

Saudi Arabia Eye Drops Market, By Region:

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/akfybw

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version